What is Zithromax Z-Pak and how does it work. What are the common uses for Zithromax Z-Pak. How should Zithromax Z-Pak be taken. What are the potential side effects of Zithromax Z-Pak. Are there any drug interactions with Zithromax Z-Pak. What precautions should be taken when using Zithromax Z-Pak. How effective is Zithromax Z-Pak for treating bacterial infections.

Understanding Zithromax Z-Pak: A Powerful Antibiotic Treatment

Zithromax Z-Pak, also known by its generic name azithromycin, is a widely prescribed antibiotic medication used to treat various bacterial infections. This potent macrolide antibiotic works by stopping the growth of bacteria, effectively combating a range of infectious diseases. But what exactly makes Zithromax Z-Pak such a popular choice among healthcare providers?

The “Z-Pak” refers to a specific dosing regimen of Zithromax, typically consisting of 250 mg tablets taken over a 5-day period. This convenient packaging and short treatment duration have contributed to its widespread use. However, it’s crucial to understand that Zithromax Z-Pak is not a one-size-fits-all solution for all types of infections.

Key Features of Zithromax Z-Pak:

• Broad-spectrum antibiotic effective against many bacterial strains
• Short treatment course (typically 5 days)
• Convenient once-daily dosing
• Available in tablet form for oral administration
• Requires a prescription from a healthcare provider

Common Uses and Indications for Zithromax Z-Pak

Zithromax Z-Pak is prescribed for a variety of bacterial infections affecting different parts of the body. Healthcare providers carefully consider the type and severity of the infection before recommending this antibiotic treatment. Which infections are most commonly treated with Zithromax Z-Pak?

Respiratory Tract Infections:

• Community-acquired pneumonia
• Acute bacterial sinusitis
• Acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD)

Skin and Soft Tissue Infections:

• Uncomplicated skin and skin structure infections
• Cellulitis

Sexually Transmitted Infections:

• Chlamydia
• Gonorrhea (in some cases)

Other Infections:

• Strep throat (group A streptococcal pharyngitis)
• Otitis media (middle ear infection) in children
• Mycobacterium avium complex (MAC) infection in people with HIV/AIDS

It’s important to note that Zithromax Z-Pak is not effective against viral infections such as the common cold or flu. Using antibiotics for viral infections can contribute to antibiotic resistance and may cause unnecessary side effects.

Proper Administration: How to Take Zithromax Z-Pak Correctly

Taking Zithromax Z-Pak as prescribed is crucial for its effectiveness and to minimize the risk of side effects. How should patients properly administer this medication?

Dosage and Administration Guidelines:

1. Follow the prescribed dosage: Typically, the Z-Pak consists of 250 mg tablets taken over 5 days.
2. Take with or without food: Zithromax can be taken with or without food, but taking it with food may help reduce stomach upset.
3. Maintain consistent timing: Try to take the medication at the same time each day to maintain steady levels in your body.
4. Complete the full course: Even if you start feeling better, it’s crucial to finish the entire prescribed course of antibiotics.
5. Avoid antacids: Do not take Zithromax Z-Pak with antacids containing aluminum or magnesium, as they can interfere with absorption.

If you miss a dose, take it as soon as you remember. However, if it’s almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Never double up on doses to make up for a missed one.

Potential Side Effects and Adverse Reactions of Zithromax Z-Pak

Like all medications, Zithromax Z-Pak can cause side effects in some individuals. While many people tolerate the medication well, it’s essential to be aware of potential adverse reactions. What are the most common and serious side effects associated with Zithromax Z-Pak?

Common Side Effects:

• Diarrhea
• Nausea
• Abdominal pain
• Vomiting
• Headache
• Dizziness

Less Common but Serious Side Effects:

• Severe allergic reactions (anaphylaxis)
• Liver problems (hepatotoxicity)
• Irregular heartbeat or QT prolongation
• Clostridium difficile-associated diarrhea
• Hearing loss or tinnitus

It’s crucial to seek immediate medical attention if you experience any severe or persistent side effects. Additionally, inform your healthcare provider about any unusual symptoms or concerns during treatment.

Drug Interactions and Precautions with Zithromax Z-Pak

Zithromax Z-Pak can interact with various medications and medical conditions, potentially altering its effectiveness or increasing the risk of side effects. What precautions should patients and healthcare providers consider when using this antibiotic?

Important Drug Interactions:

• Antacids containing aluminum or magnesium
• Blood thinners (e.g., warfarin)
• Certain heart medications (e.g., digoxin)
• Ergot derivatives
• Nelfinavir

Medical Conditions Requiring Caution:

• Liver disease
• Kidney disease
• Heart rhythm disorders
• Myasthenia gravis
• History of prolonged QT interval

Always inform your healthcare provider about all medications, supplements, and medical conditions before starting Zithromax Z-Pak. This includes over-the-counter products and herbal supplements.

Effectiveness and Limitations of Zithromax Z-Pak in Treating Infections

While Zithromax Z-Pak is highly effective against many bacterial infections, it’s important to understand its limitations and potential concerns regarding antibiotic resistance. How effective is Zithromax Z-Pak, and what factors influence its success in treating infections?

Factors Affecting Effectiveness:

• Proper diagnosis of bacterial infection
• Susceptibility of the bacterial strain to azithromycin
• Patient compliance with the prescribed regimen
• Individual patient factors (e.g., immune system function)

Zithromax Z-Pak has shown high efficacy rates in treating many common bacterial infections when used appropriately. However, the growing concern of antibiotic resistance highlights the importance of judicious use of this and other antibiotics.

Antibiotic Resistance Concerns:

The overuse and misuse of antibiotics, including Zithromax Z-Pak, can contribute to the development of antibiotic-resistant bacteria. This occurs when bacteria evolve to survive in the presence of antibiotics, making infections harder to treat. To combat this issue, healthcare providers are increasingly cautious about prescribing antibiotics and may recommend alternative treatments when appropriate.

Preventing Infections and Alternatives to Antibiotic Use

While Zithromax Z-Pak is an effective treatment for many bacterial infections, prevention remains the best approach to maintaining good health. What strategies can individuals employ to reduce their risk of infections and minimize the need for antibiotics?

Infection Prevention Strategies:

• Practice good hand hygiene
• Maintain a healthy lifestyle (balanced diet, regular exercise, adequate sleep)
• Stay up-to-date with recommended vaccinations
• Avoid close contact with sick individuals when possible
• Practice safe sex to prevent sexually transmitted infections

Alternatives to Antibiotics for Viral Infections:

For viral infections like the common cold or flu, which do not respond to antibiotics, consider the following supportive treatments:

• Rest and adequate hydration
• Over-the-counter pain relievers and fever reducers
• Nasal decongestants or saline sprays
• Throat lozenges or warm salt water gargles
• Humidifiers to ease congestion

Remember, antibiotics like Zithromax Z-Pak should only be used when prescribed by a healthcare provider for confirmed bacterial infections. Unnecessary antibiotic use can lead to resistance and potential side effects without providing any benefit for viral illnesses.

The Future of Antibiotic Treatment and Zithromax Z-Pak

As the medical community continues to grapple with the challenge of antibiotic resistance, the role of medications like Zithromax Z-Pak is evolving. What does the future hold for this popular antibiotic, and how might treatment approaches change?

Emerging Trends in Antibiotic Use:

• Increased emphasis on antibiotic stewardship programs
• Development of rapid diagnostic tests to quickly identify bacterial infections
• Research into new antibiotic classes and alternative treatment approaches
• Greater focus on personalized medicine to optimize antibiotic selection

While Zithromax Z-Pak remains an important tool in treating bacterial infections, its use may become more targeted and selective in the future. Healthcare providers may increasingly rely on diagnostic tests to confirm the need for antibiotics and choose the most appropriate treatment option.

The Role of Patient Education:

As the landscape of antibiotic use changes, patient education becomes increasingly important. Understanding when antibiotics are necessary, how to take them correctly, and the importance of completing prescribed courses can help combat antibiotic resistance and ensure the continued effectiveness of medications like Zithromax Z-Pak.

In conclusion, Zithromax Z-Pak remains a valuable antibiotic treatment for many bacterial infections when used appropriately. By understanding its proper use, potential side effects, and limitations, patients and healthcare providers can make informed decisions about its use. As we move forward, a balanced approach that combines judicious antibiotic use with effective prevention strategies will be crucial in maintaining public health and combating the threat of antibiotic resistance.

Zithromax Z-Pak Oral Tablet 250 mg

Uses

For treating bacterial infection.

Instructions

This medicine may be taken with or without food.

You may take with food to prevent stomach upset.

Keep the medicine at room temperature. Avoid heat and direct light.

Do not take this medicine with antacids.

It is important that you keep taking each dose of this medicine on time even if you are feeling well.

If you forget to take a dose on time, take it as soon as you remember. If it is almost time for the next dose, do not take the missed dose. Return to your normal dosing schedule. Do not take 2 doses of this medicine at one time.

Please tell your doctor and pharmacist about all the medicines you take. Include both prescription and over-the-counter medicines. Also tell them about any vitamins, herbal medicines, or anything else you take for your health.

It is very important that you continue using this medicine for the full number of days that it is prescribed. Please do not stop the medicine even if you start to feel better after the first few days.

Cautions

Tell your doctor and pharmacist if you ever had an allergic reaction to a medicine. Symptoms of an allergic reaction can include trouble breathing, skin rash, itching, swelling, or severe dizziness.

Do not use the medication any more than instructed.

Please tell your doctor if you have moderate to severe diarrhea while on this medicine. Do not treat the diarrhea with over-the-counter diarrhea medicine.

Tell the doctor or pharmacist if you are pregnant, planning to be pregnant, or breastfeeding.

Ask your pharmacist if this medicine can interact with any of your other medicines. Be sure to tell them about all the medicines you take.

Please tell all your doctors and dentists that you are on this medicine before they provide care.

Do not start or stop any other medicines without first speaking to your doctor or pharmacist.

Do not share this medicine with anyone who has not been prescribed this medicine.

Side Effects

The following is a list of some common side effects from this medicine. Please speak with your doctor about what you should do if you experience these or other side effects.

• diarrhea
• nausea
• stomach upset or abdominal pain
• yeast infection of mouth
• vaginal itching or yeast infection
• vomiting

Call your doctor or get medical help right away if you notice any of these more serious side effects:

• severe, watery or bloody diarrhea
• ear problems (ringing in the ears, hearing loss)
• fainting
• swelling in the neck or throat
• fast or irregular heart beats
• symptoms of liver damage (such as yellowing of skin or eyes, dark urine, unusual tiredness or weakness; severe stomach or back pain)
• muscle weakness
• skin irritation such as redness, itching, rash, or burning
• severe stomach or bowel pain
• blurring or changes of vision
• severe or persistent vomiting

A few people may have an allergic reaction to this medicine. Symptoms can include difficulty breathing, skin rash, itching, swelling, or severe dizziness. If you notice any of these symptoms, seek medical help quickly.

Extra

Please speak with your doctor, nurse, or pharmacist if you have any questions about this medicine.

https://krames.meducation.com/V2.0/fdbpem/3223

IMPORTANT NOTE: This document tells you briefly how to take your medicine, but it does not tell you all
there is to know about it.Your doctor or pharmacist may give you other documents about your medicine.
Please talk to them if you have any questions.Always follow their advice. There is a more complete
description of this medicine available in English.Scan this code on your smartphone or tablet or use
the web address below. You can also ask your pharmacist for a printout. If you have
any questions, please ask your pharmacist.

© 2021 First Databank, Inc.

Is it safe, and does it work?

The Z pack is a 5-day antibiotic treatment that does not work on the common cold. It only works on bacterial infections. A doctor can advise on suitable treatments for the common cold.

Doctors may recommend using the Z pack occasionally, and they may explain some things to consider before using it. Prevention may be the best tool against the common cold.

In this article, we discuss whether or not the Z pack is safe to use, its impact on antibiotic resistance, and how to prevent the common cold.

Share on PinterestA person should only use a Z pack under a doctor’s supervision.

Some people have concerns about the Z pack itself due to azithromycin, which is the active ingredient in the medicine.

The United States Food and Drug Administration (FDA) have issued a safety warning about the drug, noting that the antibiotic may cause abnormal changes in the electrical activity of the heart.

This could lead to potentially fatal complications in some cases.

Some people are more at risk of experiencing difficulties from using this antibiotic, including those with:

• low blood levels of potassium or magnesium
• a slower-than-normal heart rate
• arrhythmia, or an irregular heartbeat
• prolonged QT interval, or an irregularity that causes very fast and erratic heartbeats

The FDA warn health professionals to consider the risk of fatal heart rhythms in people who are at risk of cardiovascular events before prescribing antibacterial drugs such as azithromycin.

Does using the Z pack add to antibiotic resistance?

Overusing antibiotics threatens the safety of the population by contributing to antibiotic resistance.

Bacteria constantly adapt, which is how they continue to infect the human body. The more often bacteria interact with drugs such as antibiotics, the more they must adapt. This makes them stronger.

Antibiotic overuse may eventually lead to antibiotic resistance. This essentially means that the bacteria have become immune to the antibiotics. The Centers for Disease Control and Prevention (CDC) estimate that each year in the U.S., antibiotic-resistant bacteria cause more than 23,000 deaths.

So, it is best to reserve the use of antibiotics for serious infections.

Doctors tend to prescribe a Z pack to treat a strong bacterial infection. It is an oral medication that a person can take with or without food, and the dose depends on the severity of the infection. Like most medications, it works on some types of illnesses and does not work on others.

Taking the entire course of the Z pack treatment is important. Even if the person feels better before finishing the course, incomplete treatment may lead to the infection coming back or make future infections harder to deal with.

Cold and flu

The cold and flu are two very common conditions. Both the cold and flu appear due to viral infections. The rhinovirus typically causes the cold, while the influenza virus causes the flu.

It is important to note that these are viruses. Antibiotic medications such as the Z pack target bacteria and will not affect a viral infection. The Z pack is not effective against the cold or flu.

Strep throat

Strep throat is an infection in the throat and tonsils. Its symptoms include a sore, painful throat, fever, and white spots on the tonsils and back of the mouth.

Antibiotics are effective in treating the condition because it is a bacterial infection. Despite this, the Z pack or azithromycin is usually not the first choice for treatment. Doctors often prescribe antibiotics such as amoxicillin or penicillin to treat strep throat.

Where other medications fail, or a person is allergic to these antibiotics, doctors may recommend using azithromycin. This drug is effective at killing the bacteria.

Pneumonia or bronchitis

Share on PinterestA thorough diagnosis by a healthcare professional is very important.

What appears to be a severe cold or flu may be symptoms of bacterial infections such as pneumonia or bronchitis.

This is part of the reason why a thorough diagnosis is so important. If a healthcare professional sees signs of a particularly strong pneumonia or bronchitis infection, they may recommend antibiotics.

Antibiotics such as azithromycin would be effective in these cases, since the underlying issue stems from bacteria.

Other infections

According to the U.S. National Library of Medicine, azithromycin, the active ingredient in Z pack, may also be helpful against other infectious diseases, including:

• bacterial sinusitis, a sinus infection
• urethritis, an infection of the urethra
• cervicitis, an infection of the cervix
• genital ulcer disease
• ear infection
• some skin infections

Treatment still depends on what bacteria are causing the underlying infection. This is why a thorough diagnosis is important in each case before a doctor can recommend antibiotics.

Should I take a Z pack for a cold?

There is no reason to take a Z pack to treat a cold. The common cold is a viral infection, most often a rhinovirus. Viruses are not susceptible to antibiotics such as the Z pack.

Specific antivirals may target and kill viruses, but the Z pack is not one of them. Taking the Z pack will not help with a cold in any way.

Share on PinterestA person should drink extra water when they have a common cold.

The common cold usually lasts a few days, and the body can deal with it without outside help.

So, in general, there is not much that a person needs to do when fighting a cold, as the body will do the most work.

However, there are some things a person can do to help support the body, including:

• drinking extra water
• getting plenty of rest
• avoiding too much activity

If symptoms become uncomfortable or interfere with daily life, over-the-counter drugs may help treat symptoms until the body can get rid itself of the underlying infection.

Some drugs, such as acetaminophen (Tylenol), target symptoms individually, which helps reduce fever and pain. Other drugs, such as cough syrups, may contain different medicines to treat many symptoms at once.

Always follow the instructions on the label and avoid using these drugs in children. Some drugs have children’s versions available, and anyone who is uncertain should talk to their pediatrician before dosing their child.

The common cold tends to go away on its own, as the body deals with the underlying viral infection. There are still steps a person can take to help prevent the cold or prevent the spread of the cold.

These include:

• regularly washing the hands
• covering sneezes and coughs with a tissue
• avoiding touching the face or other people’s faces

Most common illnesses, such as the cold and flu, do not generally require antibiotics. The viruses will not respond to antibiotics at all, so using them is unnecessary unless a bacterial infection is present.

If a bacterial infection is getting out of hand or the person’s health or life is at stake, the doctor might recommend antibiotics.

There is no reason to take a Z pack to treat the cold. Anyone with concerns about their health during cold and flu season may want to consider discussing their options with a healthcare professional and taking measures to protect themselves from airborne viruses.

Almost everything you need to know about the use of azithromycin in pediatric practice

_Title Almost everything you need to know about the use of azithromycin in pediatric practice
_Author
_Keywords

Since November 1991, azithromycin has become one of the most significant antimicrobials in the United States . Currently, azithromycin is approved by the US Food and Drug Administration (FDA) for use in children 6 months of age and older for the treatment of acute otitis media, acute bacterial sinusitis, community acquired pneumonia, pharyngitis, and tonsillitis.[1-3] This issue of Pediatric Pharmacotherapy describes the results of clinical studies of azithromycin in children, as well as the pharmacology, dosing and monitoring of the action of this antimicrobial drug in the pediatric population.

Mechanism of action / Antibacterial spectrum
Azithromycin is an azalide antibiotic. It reversibly binds to more than 50S ribosomal subunits of sensitive microorganisms, disrupting microbial protein synthesis. Both in vitro and in clinical observations, azithromycin is active against the following gram-positive microorganisms: Staph. aureus, Strep. agalactiae, Strep. pneumoniae and Strep. pyogenes. It is also active against several Gram-negative organisms, including Haemophilus influenzae, Haemophilus ducreyi, Moraxella catarrhalis, and Neisseria gonorrhoeae, as well as other organisms such as Chlamydia pneumoniae, Chlamydia trachomatis, and Mycoplasma pneumoniae. In addition, in an in vitro experiment, azithromycin showed activity against Strep. viridans, Bordetella pertussis, Legionella pneumophilia, Prevotella bivius, Peptostreptococcus sp., Borrelia burgdoferi, Treponema pallidum, Ureaplasma urealyticum, and Mycoplasma homini .[1-3]

Recent publications
Approval of pediatric indications for the use of azithromycin is based on a large number of clinical observations that have been published over the past decade. [1] Recent clinical studies have concentrated mainly on alternative dosing regimens: shorter courses of treatment that increase patient acceptance of the treatment. The use of higher doses for shorter courses of treatment (1-3 days) is based on a more intensive accumulation of azithromycin in tissues and its long half-life (>50 hours in children). Azithromycin with these methods of administration accumulated in large quantities in neutrophils and macrophages. It is known that these cells move towards the site of infection, that is, to the area where the drug is most needed.[4]

Both one and three day regimens have been studied in the treatment of otitis media. In 2003, manufacturers sponsored a multicentre, double-blind, randomized study comparing azithromycin 10 mg/kg/day for 3 days with amoxicillin clavunate 45 mg/kg/day for 10 days.[5] The study included 188 children aged 6 months to 12 years. By ten days, a clinical effect was observed (recovery or clinical improvement was observed in 83% in the azithromycin group compared with 88% in the amoxicillin clavunate group. By day 28, cure (resolution) was observed in 74% in the azithromycin group and only in 68% in the amoxicillin group clavunate.The differences between the 10 and 28 day groups were not statistically significant.The authors consider that a short course of azithromycin is as effective as amoxicillin clavunate.

A year later, the manufacturers sponsored two other studies. The first study was an open-label study at a dose of 30 mg/kg once in 242 children.[6] By day 28, the rate of overall clinical improvement was 85%, compared with the standard 5-day course. Another study was a multicentre, double-blind study comparing high-dose azithromycin in children with persistent and recurrent otitis media.[7] Three hundred children were randomized to receive either azithromycin 20 mg/kg/day for three days or amoxicillin clavunate 90 mg/kg/day for 10 days. In the first part of the study (12 to 16 days), the clinical effect was comparable (86% for azithromycin versus 84% ​​for amoxicillin clavunate). The efficacy rate of azithromycin in the second part of the study (28 to 32 days) was significantly higher than in the amoxicillin clavunate group (72% 61% respectively). otitis media.8 In this multicentre, randomized, double-blind study, azithromycin was compared with the high-dose amoxicillin clavunate described in a previous study in 313 children aged 3 to 30 months. was 84% ​​for both azithromycin and amoxicillin clavunate.Therapy compliance was higher for azithromycin (100%) than for amoxicillin clavunate (90%).
A three-day regimen has been proposed for the treatment of community-acquired pneumonia. In 2003, Kogan et al. published the results of a randomized trial of azithromycin 10 mg/kg/day versus amoxicillin for three days at 75 mg/kg/day for 7 days, in classic pneumonia and erythromycin 50 mg/kg/day for 14 days for SARS.[9] The total number of children involved in the study was 110 people. By the end of the course of treatment, X-ray data were more often normal in the group of children treated with azithromycin than in other groups. Children with SARS who were treated with azithromycin also had a shorter cough period than those who received erythromycin (3.6+1.9days compared to 5.5+3.6 days).

In addition to the FDA-approved indications, some publications that have appeared over the past year have expanded indications for the use of azithromycin. Langley et al showed that oral azithromycin (10 mg/kg per day followed by 5 mg/kg for 2–5 days) was as effective as erythromycin estolate at 40 mg/day in the treatment of whooping cough. kg/day for ten days).[10] This multicentre, randomized study included 477 children aged (6 months to 16 years). All patients showed bacterial eradication by the end of the course of treatment. No relapses reported. Compliance was significantly higher in the group of patients treated with azithromycin (90%) compared with the group of patients taking erythromycin (55%).

Frenck et al followed 149 children (3-17 years of age) with uncomplicated typhoid fever who were treated with oral azithromycin 20 mg/kg/day compared with standard therapy with ceftriaxone 75 mg/kg/day intravenously for 5 days. [11] Cure occurred in 94% of cases in patients treated with azithromycin versus 97% in the group of patients treated with ceftriaxone. Miron et al studied the efficacy of oral azithromycin as an alternative to nalidixic acid in children with Shigella gastroenteritis. azithromycin (10 mg/kg/day) for persistent diarrhea. All azithromycin-treated patients had diarrhea resolved within 48 hours of starting treatment, versus 65% in the nalidixic acid group. Other publications have documented the efficacy of oral azithromycin (500 mg thrice weekly) and immediate topical 2% formulation in the treatment of acne vulgaris.[13,14]

Pharmacokinetics
The bioavailability of azithromycin after oral administration is approximately 40%. Appointment with food, especially with fatty meat increases the maximum concentration, but does not affect the overall absorption of the drug. In a study of adults receiving a standard dose of 500 mg per day for 1 day and a subsequent dose of 250 mg for days 2-5, the maximum concentration was 0. 24 μg / ml, and the time to maximum concentration was 3.2 hours and the average area under the concentration arc (under the concentration curve -AUC) 2.1 µg·h/ml. Azithromycin is widely distributed throughout the body, with a volumetric distribution in adults of 31.1 L/kg. Protein binding is concentration dependent, ranging from 7 to 51%. Azithromycin penetrates well into the lungs, tonsils and middle ear fluid, and this concentration exceeds that in the blood. Despite the fact that azithromycin is extensively distributed in tissues, only minimal concentrations of this drug are recorded in the cerebrospinal fluid. [2,3]
In primary elimination, azithromycin is eliminated by biliary excretion, unchanged. Only 6-14% of the dose is excreted unchanged in the urine. Azithromycin has a clear clearance of 630 ml/min in adults, with a half-life of 68 hours.[2,3]
The pharmacokinetic profile of oral erythromycin in children has been studied in two clinical studies. In the first observation, the dosage was (10 mg/kg on the first day, and in the subsequent 2-5 days 5 mg/kg). children from 6 to 15 years of age. On day 5, the mean maximum concentration was 0.224 μg/ml in younger patients, compared with a maximum concentration of 0.383 μg/ml in older children.

The AUC was also lower in younger children (1.8 µg·h/ml versus 3.1 µg·h/ml). A similar effect of age on AUC was demonstrated by a third study of 9 children at a dose of 12 mg/kg. Clearance in this study was 5.4 L/h/kg, with a half-life of 55 hours after a 5-day course of treatment.[17]
Earlier this year, Jacobs et al reported the pharmacokinetics of a single 10 mg/kg intravenous (IV) dose of azithromycin in 32 children aged 0.5 to 16 years.[18] The mean maximum concentration was 2.4 µg/ml, with an AUC of 8.2 µg·hour/ml, volume of distribution 44.1 l/kg, clearance 15.3 ml/min/kg, elimination half-life 65.2 hours. Despite the fact that all studies dealt with oral therapy, pharmacokinetic parameters did not change significantly with age.

Side effects
Azithromycin is generally well tolerated. In pediatric studies, the most common adverse events were diarrhea (1-6%), abdominal pain (1-4%), nausea (0.5-2%), vomiting (1-6%), headache (1-6%). 2%) and rash (0.4-2%). Less common side effects included dizziness, agitation, sleep disturbances, fatigue, fever, constipation, loss of appetite, chest pain, and itchy rash. Transient neutropenia has also been reported. Treatment-related urinary difficulties were observed in approximately 1%.[2,3,19]

Severe allergic reactions have been reported with azithromycin, which include anaphylactic shock, angioedema, Stevens Johnson Syndrome, and toxic epidermal necrolysis. Cases of cholestatic jaundice have been associated with erythromycin.[2,3] A case of azithromycin-associated nephritis was recently reported in a 14-year-old girl.[20] The patient had a serum creatinine level of 2.2 mg/dl two weeks after treatment, but was slowly recovering. Serum creatinine dropped to 0.8 mg/dL. A second course of azithromycin three months later resulted in more severe renal impairment. She recovered without further sequelae and had a serum creatinine of 1.2 mg/dl a year after the second episode. Azithromycin should be used with caution in patients with known renal and hepatic dysfunction. We add that the phenomena of pseudomembranous enterocolitis can complicate the use of azithromycin, as well as other antimicrobial agents.[2,3]

Drug interactions
Concurrent use of antacids and erythromycin may reduce peak serum levels but does not appear to affect total absorption. The appointment of azithromycin with nelfinavir (nelfinavir) leads to an increase in serum concentrations. There is a report that azithromycin can increase the level of serum concentrations of cyclosporine, in the event that both drugs are taken simultaneously. Patients taking this combination should be closely monitored. The use of azithromycin in patients receiving HMG-CoA inhibitors is fraught with an increased risk of myopathy and rhabdomyolysis. [2,3]

Prescribing any macrolide antibiotics with pimozide is contraindicated. Two cases of sudden death have been reported when clarithromycin was combined with pimozide.[2]

Dosage and Administration
For children six months old and older with acute otitis media, there are three accepted oral dosages: subsequent days 2) 10 mg/kg once daily for 3 days; and 3) 30 mg/kg given as a single dose. For children with acute bacterial sinusitis, a dose of 10 mg/kg administered once for 3 days is recommended.[1-3]

In children with community-acquired pneumonia, the conventional regimen is 10 mg/kg on the first day, followed by 5 mg/kg for the next 2 days.[1-3] An alternative dosage of 10 mg/kg/day for 3 days has been studied. [9] In the treatment of pharyngitis and tonsillitis in children 2 years of age and older, a dose of 12 mg/kg body weight should be given once daily for 5 days.[1-3] A dose of 20 mg/kg/day for 3 days has been demonstrated to be effective, but this method is not reflected in the instructions for use.[4]

For children with chlamydial infection older than 8 years of age who weigh more than 45 kg, the Centers for Disease Control and Prevention (CDC) recommends azithromycin 1 gram orally as a single dose. [2]
In adults, intravenous azithromycin 1 dose of 500 mg given once daily is recommended. Although this route is not currently approved by the FDA, intravenous administration is being studied in children as an intravenous dose of 10 mg/kg administered over 1 hour per day.[18]
Availability
Azithromycin is available as Zithromax® (Pfizer, Inc.) as 250 and 500 mg tablets, 600 mg capsules, 100 mg/5 ml and 200 mg/5 ml oral suspensions, 1 gram dry powder (mixable with 60 ml of water for use in adults and as an injection of 500 mg/10 ml Oral forms are presented as powder for dissolution Once prepared, the suspension can be stored at room conditions for up to ten days.[3]

Cost
retail Z-pak® (6 x 250mg Zithromax tablets) typically starts at $49.00 to $55.00 . The average cost of 15 ml or 100 mg/5 ml and 200 mg/5 ml suspension ranges from $30.00 to $38.00. The cost of an injection is approximately $26.00 to $30.00 for a 500 mg vial.[21]

Summary
Azithromycin is a common choice for many pediatric infections, including otitis media and pharyngitis. It is effective not only in traditional treatment regimens, but also demonstrates its advantages in short-term treatment. Research on this drug is ongoing, new dosing regimens are being proposed, and new patient populations are being investigated.

Refs:
1. Langtry HD, Balfour JA. Azithromycin: a review of its use in pediatric infectious diseases. Drugs 1998;56:273-97.
2. Azithromycin. Drug Facts and Comparisons. Efacts [online]. 2005 Available from Wolters Kluwer Health, Inc. Accessed 3/16/05.
3. Zithromax® prescribing information. Pfizer Inc., January 2004.
4. Gordon EM, Blumer JL. Rationale for single and high dose treatment regimens with azithromycin. Pediatr Infect DisJ 2004;23:S102-7.
5. Dunne MW, Latiolais T, Lewis B, et al. Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media. J Antimicrob Chemother 2003;52:469-72.
6. Dunne MW, Khurana C, Mohs AA, et al. Efficacy of single-dose azithromycin in treatment of acute otitis media in children after a baseline tympanocentesis. Antimicrob Agent Chemother 2003;47:2663-5.
7. Arrieta A, Arguedas A, Fernandez P, et al. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. Antimicrob Agent Chemother 2003;47:3179-86.
8. Arguedas A, Emparazna P, Schwartz RH, et al. A randomized, multicenter, double blind, double dummy trial of single dose azithromycin versus high dose amoxicillin for treatment of uncomplicated acute otitis media. Pediatr Infect Dis J 2005;24:153-61.
9. Kogan R, Martinez MA, Rubilar L, et al. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children. Pediatr Pulmonol 2003;35:91-8.
10. Langley JM, Halperin SA, Boucher FD, et al. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics 2004;114:96-101.
11. Frenck RW, Mansour A, Nakhla I, et al. Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. Clin Infect Dis 2004;38:951-7.
12. Miron D, Torem M, Merom R, et al. Azithromycin as an alternative to nalidixic acid in the therapy of childhood shigellosis. Pediatr Infect DisJ 2004;23:367-8.
13. Kapadia N, Talib A. Acne treated successfully with azithromycin. Int J Dermatol 2004;43:766-7.
14. McHugh RC, Rice A, Sangha ND, et al. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea. J Dermatol Treat 2004;15:295-302.
15. Nahata MC, Koranyi KI, Gadgil SD, et al. Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. Antimicrob Agents Chemother 1993;37:314-6.
16. Nahata MC, Koranyi KI, Luke DR, et al. Pharmacokinetics of azithromycin in pediatric patients with acute otitis media. Antimicrob Agents Chemother 1995;39:1875-7.